Down-regulation of MYC protein expression in different animal models of human malignancies leads to tumor regression, indicating that MYC proteins represent interesting therapeutic targets (Pelengaris et al., 1999; Morgenstern and Anderson, 2006). Here, MYC is linked to neoplasm.